XenOPAT, mouse models for personalized cancer treatment
On September 8th, the company XenOPAT SL, a spin-off of the Institute of Biomedical Research (IDIBELL) and the Catalan Institute of Oncology (ICO) was established with the aim of bringing the company the latest scientific ...
Sep 23, 2014
0
0